Franklin Genomic Advancem... (HELX)
CBOE: HELX
· Real-Time Price · USD
31.82
-0.00 (-0.01%)
At close: Oct 02, 2025, 10:32 AM
HELX Holdings List
As of Sep 29, 2025
The Franklin Genomic Advancements ETF is an equity ETF with a total of 59 individual holdings.
The top holdings are Natera at 5.93%, Alnylam Pharmaceuticals at 4.89%, Guardant Health at 4.81%, Medpace s at 4.69%, and Insmed Incorporated at 4.14%.
59
41.88%
Equity
16.78M
31.46
0.5000%
Sector Allocation
| Rank | Symbol | Name | Price | % Change | Shares | % Weight |
|---|---|---|---|---|---|---|
| 1 | NTRA | Natera, Inc. | 160.49 | -0.7% | 6.04K | 5.93% |
| 2 | ALNY | Alnylam Pharmac... | 450.50 | -2.2% | 1.82K | 4.89% |
| 3 | GH | Guardant Health... | 60.97 | -2.68% | 13.3K | 4.81% |
| 4 | MEDP | Medpace Holding... | 527.67 | -2.98% | 1.57K | 4.69% |
| 5 | INSM | Insmed Incorpor... | 146.73 | -0.38% | 5.02K | 4.14% |
| 6 | KRYS | Krystal Biotech... | 180.53 | +0.51% | 3.74K | 3.78% |
| 7 | UTHR | United Therapeu... | 439.94 | +0.40% | 1.42K | 3.71% |
| 8 | TEM | Tempus AI, Inc. | 87.92 | -0.09% | 7.17K | 3.39% |
| 9 | LGND | Ligand Pharmace... | 177.13 | -1.09% | 3.21K | 3.29% |
| 10 | ADPT | Adaptive Biotec... | 14.19 | -2.53% | 40.82K | 3.25% |
| 11 | BBIO | BridgeBio Pharm... | 52.03 | -2.71% | 10.1K | 3.05% |
| 12 | VRTX | Vertex Pharmace... | 408.06 | +0.95% | 1.22K | 2.82% |
| 13 | CTVA | Corteva, Inc. | 62.80 | +2.16% | 6.8K | 2.79% |
| 14 | AZN | AstraZeneca PLC | 83.09 | -1.51% | 6.07K | 2.70% |
| 15 | LLY | Eli Lilly and C... | 815.50 | -1.2% | 536 | 2.34% |
| 16 | BNTX | BioNTech SE | 103.41 | +1.17% | 3.67K | 2.17% |
| 17 | WGS | GeneDx Holdings... | 114.44 | +0.89% | 3.05K | 2.15% |
| 18 | REGN | Regeneron Pharm... | 600.22 | +0.05% | 612 | 2.08% |
| 19 | EXAS | Exact Sciences ... | 56.06 | -0.66% | 5.26K | 1.70% |
| 20 | NBIX | Neurocrine Bios... | 136.48 | -0.38% | 1.76K | 1.51% |
Page 1 of 3